Avastin for PDR (Proliferative Diabetic Retinopathy)
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of Southern California
- Study ID
- NCT01270542
- Status
- Completed
Conditions
- Diabetic Retinopathy
- Retinal Detachment
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Avastin (bevacizumab) — DRUGsingle 0.05 mL intravitreal injection of bevacizumab 1.25 mg
- Sham injection — OTHERSubject's eyes will be anesthetized but no injection will be performed.
Study Details
The purpose of this study is to determine the effect of anti-VEGF drug (Avastin) adminstration in eyes prior to surgical treatment for Traction retinal detachment (TRD) in patients with Proliferative Diabetic Retinopathy (PDR).
Key Dates
- First listed
- Jan 5, 2011
- Start date
- Jun 30, 2009
- Status verified
- May 2014
- Primary completion
- Jul 31, 2011
- Completion
- Jul 31, 2012
Study Design
- Enrollment
- 20 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Avastin Injection Group (AIG)Subjects in this group will get single 0.05 mL intravitreal injection of bevacizumab 1.25 mg 3-7 days prior to surgery for tractional retinal detachment secondary to Proliferative Diabetic Retinopathy.
- Sham Comparator: Sham Injection Group (SIG)Subjects in this group will get a sham injection 3-7 days prior to surgery for tractional retinal detachment secondary to Proliferative Diabetic Retinopathy.
Primary Outcome Measure
The Effect of an Anti-VEGF (Vascular Endothelial Growth Factor) Agent, Bevacizumab, on Levels of Vitreous and Aqueous Growth Factor Levels (pg/mL) in Eyes With Traction Retinal Detachment Due to PDR [ Time Frame: 3 months after last surgery ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90033 | - |
Find similar trials in Los Angeles, CA
By condition
By specialty
By research site
Related Studies
- Village-Integrated Eye Worker Trial IIRecruiting · University of California, San Francisco · San Francisco, California
- A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01PHASE2 · Recruiting · Vantage Biosciences Ltd · Beverly Hills, California
- Strategies for Improving Linkage-to-Care After Eye Disease ScreeningRecruiting · University of California, San Francisco · San Francisco, California
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic RetinopathyPHASE1 · Recruiting · Hoffmann-La Roche · Glendale, California